3,4-dihydroquinazoline derivatives
    1.
    发明授权
    3,4-dihydroquinazoline derivatives 失效
    3,4-二氢喹唑啉衍生物

    公开(公告)号:US08168646B2

    公开(公告)日:2012-05-01

    申请号:US12598734

    申请日:2008-05-06

    IPC分类号: A61K31/517

    CPC分类号: C07D239/84 A61K31/517

    摘要: Disclosed are 3,4-dihydroquinazoline derivatives of formula (I), a process of preparing them and a pharmaceutical composition including them. The 3,4-dihydroquinazoline derivatives of the present invention have excellent T-type calcium channel blocking effect and anti-cancer activity

    摘要翻译: 公开了式(I)的3,4-二氢喹唑啉衍生物,其制备方法和包含它们的药物组合物。 本发明的3,4-二氢喹唑啉衍生物具有优异的T型钙通道阻断作用和抗癌活性

    Process for preparing 2′-deoxy-2′, 2′-difluorocytidine
    2.
    发明授权
    Process for preparing 2′-deoxy-2′, 2′-difluorocytidine 失效
    制备2'-脱氧-2',2'-二氟胞苷的方法

    公开(公告)号:US07994310B2

    公开(公告)日:2011-08-09

    申请号:US12532331

    申请日:2008-03-20

    IPC分类号: C07H19/073

    CPC分类号: C07H1/00 C07H19/06 Y02P20/55

    摘要: Disclosed is a method for preparing 2′-deoxy-2′,2′-difluorocytidine of Formula I comprising, preparing an optically pure 3R-hydroxypropane amide compound of Formula VIII from an optical ester compound of Formula IX using an optically active chiral amine, preparing an optically pure D-erythro-2,2-difluoro-2-deoxy-1-oxoribose compound of Formula V from the compound of Formula VIII, glycosylating the compound of Formula V with a nucleobase to prepare the 2′-deoxy-2′,2′-difluorocytidine of Formula I as a β-nucleoside. With the present invention, it is possible to prepare an optically pure compound of Formula I in a high purity and a high yield. In the Formulae, R1 and R2 are protecting groups and are each independently benzoyl, 4-methylbenzoyl, 3-methylbenzoyl, 4-cyanobenzoyl, 3-cyanobenzoyl, 4-propylbenzoyl, 2-ethoxybenzoyl, 4-t-butylbenzoyl, 1-naphthoyl or 2-naphthoyl, R3, R4 and R7 are each independently C1-C3 alkyl, R5 is methyl or ethyl, R6 is hydrogen, methyl or methoxy.

    摘要翻译: 公开了一种制备式I的2'-脱氧-2',2'-二氟胞苷的方法,其包括:使用光学活性手性胺由式IX的光学酯化合物制备光学纯的3R-羟基丙酰胺化合物, 从式VIII化合物制备光学纯的D-型赤式-2,2-二氟-2-脱氧-1-氧代核糖核糖化合物,用式I化合物将式V化合物糖基化,从而制备2'-脱氧-2 ',式I的2'-二氟胞苷作为核苷。 通过本发明,可以以高纯度和高收率制备光学纯的式I化合物。 在式中,R 1和R 2是保护基,各自独立地是苯甲酰基,4-甲基苯甲酰基,3-甲基苯甲酰基,4-氰基苯甲酰基,3-氰基苯甲酰基,4-丙基苯甲酰基,2-乙氧基苯甲酰基,4-叔丁基苯甲酰基,1-萘甲酰基或 2-萘甲酰基,R3,R4和R7各自独立地为C1-C3烷基,R5为甲基或乙基,R6为氢,甲基或甲氧基。

    PROCESS FOR PREPARING OF 2'-DEOXY-2'2'-DIFLUOROCYTIDINE
    4.
    发明申请
    PROCESS FOR PREPARING OF 2'-DEOXY-2'2'-DIFLUOROCYTIDINE 失效
    制备2'-脱氧-2'-脱氧胆碱的方法

    公开(公告)号:US20100069625A1

    公开(公告)日:2010-03-18

    申请号:US12532331

    申请日:2008-03-20

    IPC分类号: C07H19/06 C07H3/02 C07D317/08

    CPC分类号: C07H1/00 C07H19/06 Y02P20/55

    摘要: Disclosed is a method for preparing 2′-deoxy-2′,2′-difluorocytidine of Formula I comprising, preparing an optically pure 3R-hydroxypropane amide compound of Formula VIII from an optical ester compound of Formula IX using an optically active chiral amine, preparing an optically pure D-erythro-2,2-difluoro-2-deoxy-1-oxoribose compound of Formula V from the compound of Formula VIII, glycosylating the compound of Formula V with a nucleobase to prepare the 2′-deoxy-2′,2′-difluorocytidine of Formula I as a β-nucleoside. With the present invention, it is possible to prepare an optically pure compound of Formula I in a high purity and a high yield. In the Formulae, R1 and R2 are protecting groups and are each independently benzoyl, 4-methylbenzoyl, 3-methylbenzoyl, 4-cyanobenzoyl, 3-cyanobenzoyl, 4-propylbenzoyl, 2-ethoxybenzoyl, 4-t-butylbenzoyl, 1-naphthoyl or 2-naphthoyl, R3, R4 and R7 are each independently C1-C3 alkyl, R5 is methyl or ethyl, R6 is hydrogen, methyl or methoxy.

    摘要翻译: 公开了一种制备式I的2'-脱氧-2',2'-二氟胞苷的方法,其包括:使用光学活性手性胺由式IX的光学酯化合物制备光学纯的3R-羟基丙酰胺化合物, 从式VIII化合物制备光学纯的D-型赤式-2,2-二氟-2-脱氧-1-氧代核糖核糖化合物,用式I化合物将式V化合物糖基化,从而制备2'-脱氧-2 ',式Ⅰ的2'-二氟胞苷作为核苷。 通过本发明,可以以高纯度和高收率制备光学纯的式I化合物。 在式中,R 1和R 2是保护基,各自独立地是苯甲酰基,4-甲基苯甲酰基,3-甲基苯甲酰基,4-氰基苯甲酰基,3-氰基苯甲酰基,4-丙基苯甲酰基,2-乙氧基苯甲酰基,4-叔丁基苯甲酰基,1-萘甲酰基或 2-萘甲酰基,R3,R4和R7各自独立地为C1-C3烷基,R5为甲基或乙基,R6为氢,甲基或甲氧基。